RED 152005
Latest Information Update: 17 Apr 2007
At a glance
- Originator XiMed Group
- Class Antiparasitics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pediculosis
Most Recent Events
- 17 Apr 2006 Discontinued - Phase-I for Pediculosis in United Kingdom (Topical)
- 17 Nov 2003 Ximed Group is now called Eden Research
- 08 Jan 2001 Phase-I clinical trials for Pediculosis in United Kingdom (Topical)